U.S. Companion Diagnostics Markets

U.S. Companion Diagnostics Markets published by Frost & Sullivan in December, 2009. This report consists of 104 Pages and the price starts from US $ 6000.

Introduction

This analysis provides a detailed view of the U.S. companion diagnostics market. This segments present an executive summary highlighting key analysis and findings pertaining to the market. In addition, industry challenges and strategies for growth are in depth for the U.S. companion diagnostics market. Key developing business models in the market are also discussed.

1. Executive Summary

Market Overview

• Introduction

2. Market Introduction

Research Scope and Methodology

• Scope
• Methodology

Market Overview

• Market Engineering Measurements
• Introduction
• Current Trends in Companion Diagnostics
• FDA' s Concept Paper
• Biomarkers and Companion Diagnostics

Market Drivers and Restraints

• Market Drivers
• Market Restraints

Industry Challenges and Strategic Recommendations

• Industry Challenges
• Strategic Recommendations

3. Reimbursement Analysis

Reimbursement Overview

• Introduction
• Insurance and Payment

Companion Diagnostics Reimbursement Policies

• Reimbursement Determination
• Policy Summary

4. Market Analysis

Competitive Structure

• Competitive Analysis
• Mergers & Acquisitions and Partnerships

Business Model Analysis

• External Partnership Model (Pfizer & Monogram Biosciences)
• Integrated Model (Roche)

Economics of Companion Diagnostics

• Revenue Potential & Economic Benefit: Trofile Assay
• Revenue Potential & Economic Benefit: KRAS Testing
• Future Market Potential Analysis

Related Reports